- Medtech Insight
- >>Business
Acelity Buys Crawford To Create Wound-Care Powerhouse
Acelity has agreed to acquire Crawford Healthcare for an undisclosed price to expand its wound care portfolio. Crawford's wound-dressing portfolio includes the KerraMax Care, KerraFoam, and KerraCel brands, complementing Acelity's advanced wound dressing line-up, which includes the Promogran Prisma Matrix collagen dressing, the Tielle dressings, and Adaptic dressings. The deal also includes Crawford's research and development and manufacturing facilities in Chesire, UK.
Acelity LP Inc. expects its acquisition of Crawford Healthcare to create the most comprehensive line of advanced wound-care devices available and consolidate leading positions in several rapidly growing sub-segments of that rapidly-growing market, the company said in its announcement of the deal on June 8.
Terms of the deal were not disclosed. Acelity's press release notes the deal includes Crawford's R&D capabilities and manufacturing operations...